远程医疗公司Hims & Hers Health Inc.（HIMS）今日盘中股价大涨5.06%，引起市场广泛关注。这一涨幅可能与该公司对俄亥俄州即将出台的新监管政策作出积极回应有关。
据报道，俄亥俄州正计划实施新规定，限制药物配制药房的批量生产规模，这可能影响到包括Hims & Hers在内的依赖该州药房生产特殊剂量复方药物的在线远程保健公司。Hims & Hers自2020年起在俄亥俄州拥有一家药店，去年曾表示计划利用该药店满足全国的治疗需求。
面对即将到来的监管变化，Hims & Hers公司发言人在一份声明中表示："Hims & Hers公司长期以来一直与监管机构密切合作，遵守严格的安全标准，随着要求的不断变化，我们将继续这样做。"这一表态显示出公司有信心适应新的监管环境，可能增强了投资者的信心。值得注意的是，该公司2024年的收入为14.8亿美元，其中19%来自减肥药物，这个快速增长的业务领域正是新规定可能影响的重点。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.